Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Identification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells.

Estoppey D, Hewett JW, Guy CT, Harrington E, Thomas JR, Schirle M, Cuttat R, Waldt A, Gerrits B, Yang Z, Schuierer S, Pan X, Xie K, Carbone W, Knehr J, Lindeman A, Russ C, Frias E, Hoffman GR, Varadarajan M, Ramadan N, Reece-Hoyes JS, Wang Q, Chen X, McAllister G, Roma G, Bouwmeester T, Hoepfner D.

Sci Rep. 2017 Feb 16;7:42728. doi: 10.1038/srep42728.

2.

Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed.

Mohammed AA, El-Tanni H, Atiah TA, Atiah AA, Atiah MA, Rasmy AA.

Indian J Hematol Blood Transfus. 2016 Dec;32(4):383-391. Epub 2016 Feb 12. Review.

PMID:
27812245
3.

Diet-induced obesity increases the frequency of Pig-a mutant erythrocytes in male C57BL/6J mice.

Wickliffe JK, Dertinger SD, Torous DK, Avlasevich SL, Simon-Friedt BR, Wilson MJ.

Environ Mol Mutagen. 2016 Dec;57(9):668-677. doi: 10.1002/em.22058. Epub 2016 Oct 14.

PMID:
27739633
4.

Pesg PNH diagnosis, follow-up and treatment guidelines.

Sahin F, Akay OM, Ayer M, Dal MS, Ertop S, Ilhan O, Karakus V, Ozcan MA, Ozkocaman V, Ozsan H, Salim O, Tobu M, Tombak A, Tuglular TF, Yilmaz M, Unal A, Yenerel MN, Saydam G.

Am J Blood Res. 2016 Aug 5;6(2):19-27. eCollection 2016. Review.

5.
6.

A Hispanic female patient with heartburn: A rare presentation of Paroxysmal Nocturnal Hemoglobinuria.

Figueroa-Jiménez LA, González-Márquez AL, Alicea-Guevara R, Santiago-Casiano M, de la Paz-López M, Negrón-Garcia L, Báez-Diaz L, Cáceres-Pérkins W.

Bol Asoc Med P R. 2015 Jul-Sep;107(3):9-12. Review.

7.

Complement inhibitors to treat IgM-mediated autoimmune hemolysis.

Wouters D, Zeerleder S.

Haematologica. 2015 Nov;100(11):1388-95. doi: 10.3324/haematol.2015.128538. Review.

8.

Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria.

Al-Jafar HA, AlDallal SM, Askar HA, Aljeraiwi AM, Al-Alansari A.

Hematol Rep. 2015 Sep 23;7(3):5927. doi: 10.4081/hr.2015.5927. eCollection 2015 Sep 23.

9.

Chronic myeloid leukemia transformation in a patient with paroxysmal nocturnal hemoglobinuria: a rare case report with literature review.

Chen Y, Tao S, Deng Y, Song L, Yu L.

Int J Clin Exp Med. 2015 May 15;8(5):8226-9. eCollection 2015.

10.

Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.

DeZern AE, Brodsky RA.

Hematol Oncol Clin North Am. 2015 Jun;29(3):479-94. doi: 10.1016/j.hoc.2015.01.005. Epub 2015 Mar 7. Review.

11.

Further evidence that paroxysmal nocturnal haemoglobinuria is a disorder of defective cell membrane lipid rafts.

Ratajczak MZ, Borkowska S, Mierzejewska K, Kucia M, Mendek-Czajkowska E, Suszynska M, Sharma VA, Deptala A, Song W, Platzbecker U, Larratt L, Janowska-Wieczorek A, Maciejewski J, Ratajczak J.

J Cell Mol Med. 2015 Sep;19(9):2193-201. doi: 10.1111/jcmm.12605. Epub 2015 May 29.

12.

The genotypic and phenotypic spectrum of PIGA deficiency.

Tarailo-Graovac M, Sinclair G, Stockler-Ipsiroglu S, Van Allen M, Rozmus J, Shyr C, Biancheri R, Oh T, Sayson B, Lafek M, Ross CJ, Robinson WP, Wasserman WW, Rossi A, van Karnebeek CD.

Orphanet J Rare Dis. 2015 Feb 27;10:23. doi: 10.1186/s13023-015-0243-8.

13.

Complement-mediated haemolysis and the role of blood transfusion in paroxysmal nocturnal haemoglobinuria.

Olutogun T, Cutini I, Notaro R, Luzzatto L.

Blood Transfus. 2015 Jul;13(3):363-9. doi: 10.2450/2015.0249-14. Epub 2015 Feb 2. Review. No abstract available.

14.

A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data.

Kahng J, Kim Y, Kim JO, Koh K, Lee JW, Han K.

Ann Lab Med. 2015 Jan;35(1):35-40. doi: 10.3343/alm.2015.35.1.35. Epub 2014 Dec 8.

15.

Paroxysmal nocturnal hemoglobinuria.

Brodsky RA.

Blood. 2014 Oct 30;124(18):2804-11. doi: 10.1182/blood-2014-02-522128. Epub 2014 Sep 18. Review.

16.

Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscape.

Mastellos DC, Ricklin D, Yancopoulou D, Risitano A, Lambris JD.

Expert Rev Hematol. 2014 Oct;7(5):583-98. doi: 10.1586/17474086.2014.953926. Epub 2014 Sep 2. Review.

17.

A comparative analysis of constitutive promoters located in adeno-associated viral vectors.

Damdindorj L, Karnan S, Ota A, Hossain E, Konishi Y, Hosokawa Y, Konishi H.

PLoS One. 2014 Aug 29;9(8):e106472. doi: 10.1371/journal.pone.0106472. eCollection 2014.

18.
19.

Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria.

Risitano AM, Ricklin D, Huang Y, Reis ES, Chen H, Ricci P, Lin Z, Pascariello C, Raia M, Sica M, Del Vecchio L, Pane F, Lupu F, Notaro R, Resuello RR, DeAngelis RA, Lambris JD.

Blood. 2014 Mar 27;123(13):2094-101. doi: 10.1182/blood-2013-11-536573. Epub 2014 Feb 4. Erratum in: Blood. 2017 Apr 13;129(15):2205.

20.

Supplemental Content

Support Center